Session » Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Lupus Nephritis and Genetics

Meeting: 2013 ACR/ARHP Annual Meeting

Abstract Number: 880

Role Of Urinary Podocyte Number and Urinary Podocalyxin Level As Biomarkers Of Glomerulonephritis In Systemic Lupus Erythematosus and ANCA-Associated Vasculitis

Abstract Number: 881

Time To Renal Flare and Renal Disease Activity Over a 1 Year Period Is associated With Urinary TWEAK Levels In Patients With Systemic Lupus Erythematosus

Abstract Number: 882

Association Of a Neutrophil Gene Signature Comprised Of Low Density Granulocyte (LDG)-Enriched Genes With Both Future Systemic Lupus Erythematosus Disease Activity and Poor Longterm Outcomes

Abstract Number: 883

Sex Bias In Autoimmune Diseases: Increased Risk Of 47,XXX In Systemic Lupus Erythematosus (SLE) and Sjögren’s Syndrome (SS) Supports The Gene Dose Hypothesis

Abstract Number: 884

Treatment Of Lupus Nephritis With Abatacept Plus Low-Dose Pulse Cyclophosphamide Followed By Azathioprine (the Euro-Lupus Regimen): Twenty-Four Week Data From a Double-Blind Controlled Trial

Abstract Number: 885

Fatigue In SLE Is Associated With Upregulation Of Interferon- Alpha Related Gene Transcripts

« View all sessions from this meeting